Rohto Pharmaceutical Co.,Ltd. (FRA:UC1)

Market Cap	3.50B +5.6%
Revenue (ttm)	1.90B +9.7%
Net Income	178.39M -3.4%
EPS	0.76 -6.2%
Shares Out	n/a
PE Ratio	19.59
Forward PE	n/a
Dividend	0.27 (1.79%)
Ex-Dividend Date	Sep 29, 2026

Volume	n/a
Open	15.60
Previous Close	15.70
Day's Range	15.30 - 15.60
52-Week Range	12.00 - 16.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Rohto Pharmaceutical

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 1899
• Employees: 9,292
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UC1

Financial Performance

In fiscal year 2026, Rohto Pharmaceutical's revenue was 343.73 billion, an increase of 11.37% compared to the previous year's 308.63 billion. Earnings were 34.25 billion, an increase of 10.45%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 19, 2026

Data Sources Report a data error